Corrective Phases R...
Health Care: Drugs
Dynavax Technologies Corporation (DVAX: NASDAQ)
$3.56 -0.05 | -1.38%
06/04/12 - 09:45 AM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -48.60M | -57.31M | -30.56M | -20.83M |
| Operating Gains/Losses | 20.00K | -36.00K | -4.14M | 3.42M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -8.53M | -106.00K | 5.51M | 827.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -289.00K | 643.00K | 781.00K | -3.51M |
| (Decrease) Increase In Other Current Liabilities | -2.17M | 3.38M | 762.00K | -6.13M |
| (Increase) Decrease In Other Working Capital | 3.22M | -12.76M | -31.86M | 7.35M |
| Other Non-Cash Items | 6.22M | 12.82M | 22.71M | -2.52M |
| Net Cash From Continuing Operations | -47.12M | -51.37M | -33.55M | -17.04M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -47.12M | -51.37M | -33.55M | -17.04M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 77.73M | 30.75M | 29.50M | 63.45M |
| Purchases of Property, Plant & Equipment | -1.14M | -420.00K | -377.00K | -4.10M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -111.20M | -80.84M | -14.29M | -35.76M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -34.62M | -50.50M | 19.88M | 30.12M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 2.00M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 91.31M | 87.63M | 2.33M | 209.00K |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | -817.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 132.00K | 0.00 | 19.73M | 0.00 |
| Net Cash From Financing Activities | 91.44M | 87.63M | 22.06M | 1.39M |
| Effect of Exchange Rate Changes | -218.00K | -23.00K | 235.00K | -663.00K |
| Net Change in Cash & Cash Equivalents | 9.49M | -14.27M | 8.62M | 13.81M |
Portfolios with DVAX
- Portfolio NameUser Type
- Contributor10 Stocks Boosting Little F...
- UserMy stocks
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks of Top-Performing...
- ContributorStocks At New 52-Week Highs...
- Contributor13 Biotech Stocks Bought an...
- Contributor10 Pharma Stocks Under $3
- Contributor4 Biotech Penny Stocks to Buy
- UserMy Portfolio
- UserStarters
Latest DVAX Headlines from TheStreet
- Dynavax Stock Gaps Down On Today's Open (DVAX) 05.09.12 | 09:05 am
- 10 Stocks Boosting Little Funds to Big Returns (Update2) 03.16.12 | 02:03 pm
- 8 Stocks Under $10 Moving Higher 02.02.12 | 02:02 pm
- 10 Stocks of Top-Performing Funds in 2012 01.20.12 | 10:01 am
- Biotech Calendar: Key Dates for October 10.03.11 | 08:10 am
- Biotech Calendar: Key Dates for September 08.31.11 | 06:08 am
- Dynavax Stock Gaps Down On Today's Open (DVAX) 07.20.11 | 09:07 am
- 10 Pharma Stocks Under $3 06.16.11 | 01:06 pm
- 4 Biotech Penny Stocks to Buy: Navellier 04.13.11 | 11:04 am
- Dynavax, Frontier Financial: Early Volume Plays 04.27.10 | 07:04 am
Press Releases for DVAX
Partner Headlines for DVAX
- Company News for May 10, 2012 - Corporate Summary - Zacks 05.10.12 | 10:05 am
- Buy And Sell Ideas Based On Monday's Big Biotech News Movers - Seeking Alpha 10.11.11 | 08:10 am
- Dynavax Reports Diabetic Subset Data From Modified Intent to Treat Analysis of the HEPLISAV Phase 3 Trial - Benzinga 10.06.11 | 04:10 pm
- 7 Breakout Stocks With Sufficient Cash to Cover Operating Expenses - Seeking Alpha 03.29.11 | 08:03 am
- Data from Dynavax for HBV Candidate - Analyst Blog - Zacks 12.27.10 | 01:12 pm
- Dynavax Announces $30 Million Common Stock Purchase (DVAX) - Benzinga 09.20.10 | 04:09 pm
- UPDATE 1-Dynavax posts Q2 loss, shares fall - Reuters 07.30.10 | 05:07 pm
- UPDATE 1-Dynavax's flu vaccine shows promise, shares rise - Reuters 04.26.10 | 05:04 pm
- Healthcare, Technology Converge: Recent Biotech Deals - SeekingAlpha.com 04.19.10 | 05:04 am
- UPDATE 1-Dynavax hep B vaccine shows promise in kidney disease - Reuters 04.14.10 | 05:04 pm
